Baidu
map
NPJ PARKINSONS DIS 润色咨询

npj Parkinsons Disease

出版年份：暂无数据 年文章数：314 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2024-06-15 Doc.颖儿 来自江苏省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：帕金森病
    经验分享：第一次审稿大修
    Revision Received 31st Mar 24
    Waiting for Revision 23rd Feb 24
    Decision Sent to Author 23rd Feb 24
    Waiting to Send Decision to Author 22nd Feb 24
    Manuscript Under Consideration 17th Feb 24
    17th Feb 24
    Manuscript Under Consideration 28th Jan 24
    22nd Jan 24
    Manuscript Under Consideration 22nd Dec 23
    Editor Assigned 22nd Dec 23
    Manuscript Received 18th Dec 23

    Stage Start Date
    Revision Received 3rd Jun 24 01:51:29
    Waiting for Revision 31st May 24 11:45:11
    Decision Sent to Author 31st May 24 11:45:11
    Waiting to Send Decision to Author 25th May 24 08:42:43
    Manuscript Under Consideration 24th May 24 12:11:10
    24th May 24 12:11:10
    Manuscript Under Consideration 23rd May 24 10:08:37
    Editor Assigned 13th May 24 09:47:24
    Manuscript Received 13th May 24 09:47:23

    第三轮小修 2周左右时间 接受

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-02-23 ms6000000926635472

    Decision Sent to Author 21st Feb 22
    Waiting to Send Decision to Author 18th Feb 22
    Manuscript Under Consideration 18th Feb 22
    Manuscript Under Consideration 31st Jan 22
    Editor Assigned 24th Jan 22
    Manuscript Received 24th Jan 22

    2.15才分配编辑
    I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.

    真慢啊

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-05-20 guanqianglu

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-04-27 498260625

    投稿命中率:25.0
    偏重的研究方向：帕金森病
    经验分享：投稿40天左右收到送审邮件，还在等待中

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-03-31 ms9000001319861801

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：初审两个月才拒，实在太慢了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-02-23 ms6000000926635472

    不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-02-15 梅斯助教

    #期刊推荐#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2210066, encodeId=8bf922100662d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：第一次审稿大修<br>Revision Received 31st Mar 24 <br>Waiting for Revision 23rd Feb 24 <br>Decision Sent to Author 23rd Feb 24 <br>Waiting to Send Decision to Author 22nd Feb 24<br>Manuscript Under Consideration 17th Feb 24 <br>17th Feb 24<br>Manuscript Under Consideration 28th Jan 24 <br>22nd Jan 24<br>Manuscript Under Consideration 22nd Dec 23 <br>Editor Assigned 22nd Dec 23 <br>Manuscript Received 18th Dec 23 <br><br>Stage Start Date<br>Revision Received 3rd Jun 24 01:51:29<br>Waiting for Revision 31st May 24 11:45:11<br>Decision Sent to Author 31st May 24 11:45:11<br>Waiting to Send Decision to Author 25th May 24 08:42:43<br>Manuscript Under Consideration 24th May 24 12:11:10<br>24th May 24 12:11:10<br>Manuscript Under Consideration 23rd May 24 10:08:37<br>Editor Assigned 13th May 24 09:47:24<br>Manuscript Received 13th May 24 09:47:23<br><br>第三轮小修 2周左右时间 接受<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI4gnS2OkQJooRMiaZGsBWf8IO1GoiaGHMLRIgESib6tv7tUT6Rm4WSt9bibkszJH6glDRrczszfU4DqA/132, createdBy=4d002087625, createdName=Doc.颖儿, createdTime=Sat Jun 15 22:48:36 CST 2024, time=2024-06-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22<br>Waiting to Send Decision to Author 18th Feb 22<br>Manuscript Under Consideration 18th Feb 22<br>Manuscript Under Consideration 31st Jan 22 <br>Editor Assigned 24th Jan 22<br>Manuscript Received 24th Jan 22<br><br>2.15才分配编辑<br>I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.<br><br>真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：帕金森病<br>经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration<br>2021/08/24 Associate Editor assigned<br>2021/08/27 Manuscript Under Consideration<br>2021/09/01 Waiting to Send Decision to Author<br>2021/09/02 Editorial decision: Reject before peer review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-23 雪亦飘零久

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：帕金森病
    经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration
    2021/08/24 Associate Editor assigned
    2021/08/27 Manuscript Under Consideration
    2021/09/01 Waiting to Send Decision to Author
    2021/09/02 Editorial decision: Reject before peer review

    0

共14条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map